A detailed history of Saratoga Research & Investment Management transactions in Johnson & Johnson stock. As of the latest transaction made, Saratoga Research & Investment Management holds 532,439 shares of JNJ stock, worth $77.7 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares
532,439
Previous 551,753 3.5%
Holding current value
$77.7 Million
Previous $80.6 Million 7.0%
% of portfolio
3.78%
Previous 3.67%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

SELL
$145.48 - $167.38 $2.81 Million - $3.23 Million
-19,314 Reduced 3.5%
532,439 $86.3 Million
Q2 2024

Aug 16, 2024

BUY
$144.38 - $157.78 $16.2 Million - $17.7 Million
112,234 Added 25.54%
551,753 $80.6 Million
Q1 2024

Apr 17, 2024

BUY
$155.22 - $162.74 $679,397 - $712,312
4,377 Added 1.01%
439,519 $69.5 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $3.12 Million - $3.41 Million
-21,444 Reduced 4.7%
435,142 $68.2 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $286,424 - $320,868
-1,839 Reduced 0.4%
456,586 $71.1 Million
Q2 2023

Jul 24, 2023

BUY
$154.35 - $166.11 $2.78 Million - $2.99 Million
18,016 Added 4.09%
458,425 $75.9 Million
Q1 2023

May 05, 2023

BUY
$151.05 - $180.26 $5.5 Million - $6.56 Million
36,389 Added 9.01%
440,409 $68.3 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $1.99 Million - $2.23 Million
-12,419 Reduced 2.98%
404,020 $71.4 Million
Q3 2022

Oct 31, 2022

BUY
$161.33 - $179.52 $5.71 Million - $6.36 Million
35,409 Added 9.29%
416,439 $68 Million
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $3.19 Million - $3.53 Million
-18,982 Reduced 4.75%
381,030 $67.6 Million
Q1 2022

Apr 29, 2022

SELL
$158.14 - $179.59 $181,386 - $205,989
-1,147 Reduced 0.29%
400,012 $70.9 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $711,196 - $789,098
4,561 Added 1.15%
401,159 $68.6 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $1.51 Million - $1.67 Million
9,331 Added 2.41%
396,598 $64.1 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $431,074 - $462,402
2,703 Added 0.7%
387,267 $63.8 Million
Q1 2021

Apr 12, 2021

BUY
$153.07 - $170.48 $5.69 Million - $6.34 Million
37,192 Added 10.71%
384,564 $63.2 Million
Q4 2020

Feb 03, 2021

BUY
$137.11 - $157.38 $2.64 Million - $3.03 Million
19,240 Added 5.86%
347,372 $54.7 Million
Q3 2020

Oct 09, 2020

SELL
$140.38 - $153.83 $352,634 - $386,420
-2,512 Reduced 0.76%
328,132 $48.9 Million
Q2 2020

Aug 07, 2020

BUY
$128.81 - $155.51 $926,787 - $1.12 Million
7,195 Added 2.22%
330,644 $46.5 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $11.8 Million - $16.4 Million
106,284 Added 48.94%
323,449 $42.4 Million
Q4 2019

Feb 05, 2020

SELL
$127.5 - $146.44 $16,447 - $18,890
-129 Reduced 0.06%
217,165 $31.7 Million
Q3 2019

Oct 29, 2019

SELL
$126.95 - $142.14 $287,795 - $322,231
-2,267 Reduced 1.03%
217,294 $28.1 Million
Q2 2019

Jul 24, 2019

BUY
$131.15 - $144.24 $390,302 - $429,258
2,976 Added 1.37%
219,561 $30.6 Million
Q1 2019

Apr 18, 2019

BUY
$125.72 - $139.79 $32,058 - $35,646
255 Added 0.12%
216,585 $30.3 Million
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $1.67 Million - $2.01 Million
-13,562 Reduced 5.9%
216,330 $27.9 Million
Q3 2018

Oct 15, 2018

SELL
$121.58 - $142.88 $1.01 Million - $1.19 Million
-8,326 Reduced 3.5%
229,892 $31.8 Million
Q2 2018

Jul 17, 2018

SELL
$119.4 - $131.76 $1.68 Million - $1.85 Million
-14,056 Reduced 5.57%
238,218 $28.9 Million
Q1 2018

May 01, 2018

SELL
$125.1 - $148.14 $110,338 - $130,659
-882 Reduced 0.35%
252,274 $32.3 Million
Q4 2017

Jan 19, 2018

SELL
$131.22 - $143.62 $719,872 - $787,899
-5,486 Reduced 2.12%
253,156 $35.4 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $33.1 Million - $34.6 Million
255,587 Added 8366.19%
258,642 $33.6 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $395,530 - $413,585
3,055
3,055 $397,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Saratoga Research & Investment Management Portfolio

Follow Saratoga Research & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saratoga Research & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Saratoga Research & Investment Management with notifications on news.